Pernix Therapeutics Chooses Morristown, New Jersey, For New Corporate Headquarters
04/21/2014
“Establishing Pernix’s headquarters in Morristown, New Jersey continues our efforts to build Pernix into a focused specialty pharmaceutical company with an experienced management team that is well-positioned for additional product acquisitions,” Doug Drysdale, President/CEO of Pernix said.
According to the firm, its new corporate headquarters will be occupied in mid-May “and is a key step towards the achievement of several corporate initiatives, including improving the efficiency of the Company’s operational infrastructure by consolidating office locations and hiring and retaining experienced employees.”
“ The Company has shifted its emphasis from horizontal integration to focusing on its core sales and marketing strengths to build a leading specialty pharmaceutical business,” company officials said.
The Company markets a portfolio of branded products, including: CEDAX, an antibiotic for middle ear infections and a number of treatments for cough and cold conditions including ZUTRIPRO, REZIRA and VITUZ. The Company also markets SILENOR, a non-narcotic product for the treatment of insomnia and KHEDEZLA, a treatment for major depressive disorder.
Project Announcements
Kikkoman Foods Plans Jefferson, Wisconsin, Operations
04/26/2024
BWX Technologies Expands Cambridge, Ontario, Nuclear Production Operations
04/26/2024
Greenheck Group Plans Knoxville, Tennessee, Operations
04/26/2024
Local Bounti Plans Pasco, Washington, Indoor Agricultural Operations
04/26/2024
Innovative Construction Group Plans Siler City, North Carolina, Production Operations
04/26/2024
Crystal Window and Door Systems Plans Mansfield, Texas, Headquarters-Production Operations
04/25/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024